Reactivating the Fragile X Gene in Young Mice Reverses Symptoms

December 28, 2021

Fragile X syndrome might be treated by reactivating the gene which is shut down in the syndrome. Researchers were able to reduce FXS symptoms by inserting the FMR1 gene into the brains of young mice.

Read More »
David Nelson, PhD, FRAXA Investigator

Fragile X Mutant Mouse Models

September 10, 2016

With $375,000 in grants from FRAXA, Dr. David Nelson developed an array of advanced mouse models of Fragile X. These models are available at Jackson Labs (JAX).

Read More »
David Nelson lab

Researcher David Nelson, PhD, Explores New Cell Strategies for Fragile X Syndrome, FXTAS and FXPOI

May 31, 2016

David Nelson co-discovered the FMR1 mutation which causes Fragile X syndrome and developed key mouse models, enabling global research aimed at finding treatments for the disorder.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (37)